FBIN vs PFE · P/E 16, rev $4.61B vs P/E 20, rev $62.58B
Fortune Brands Innovations Inc. (FBIN) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Fortune Brands Innovations Inc. (FBIN) is a building products & equipment company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported FBIN revenue for 2024-12-28 was $4.61B. Net income was $471.9M. Revenue was down 0.4% from 2023-12-30 to 2024-12-28. FBIN currently screens at market cap $6.39B and trailing P/E 15.6.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
FBIN currently screens at market cap $6.39B and trailing P/E 15.6. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the FBIN and PFE stock pages for the full models.
Not investment advice.